[1] Arguably ... Major beta blocker mortality trials in chronic heart failure: a critical review. Heart. 1999;82(suppl 4):IV14 IV22. Altered adrenergic receptor sensitivity due to polymorphic ...
These symptoms may often be avoided or ameliorated by separating carvedilol and ACE inhibitor dosing by at least 2 hours ... within 1 day during monitoring of blood pressure and heart rate ...
In patients with familial PAH, SMAD5 appears to be a novel gene that warrants consideration for genetic testing, according to ...
Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or doesn't produce enough of it, leading to high blood sugar levels ...
Hypertension (high blood pressure) affects an estimated 1 ... beta blockers both act on the musculature of either the blood vessels and/or the heart. Beta blockers act by blocking the β-receptors ...
Background Acute kidney injury (AKI) in the context of acute decompensated heart failure (ADHF) encompasses a broad spectrum ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...
Peptides have emerged as a focal point in molecular and biological research, providing a promising avenue for understanding ...
mrc.ac.za Beta-blockers refer to an assorted group of medications that block the action of endogenous catecholamines on beta-adrenergic receptors.1 The β1 and β2 receptors ... of third-generation beta ...
Most recently they have shown that cardiodepressant but cardioprotective coupling of the β2AR underpins a naturally occurring condition (Takotsubo Syndrome), and that beta-blockers are taking ...
http://orcid.org/0000-0003-1053-7840Paul M Haydock, http://orcid.org/0000-0002-8126-9583Andrew S Flett To review the pathophysiology of heart failure with reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback